R

Rare metabolics life sciences private limited

3 employees

Heart Metabolics is a company based in UK, developing drugs to treat heart failure for hypertrophic cardiomyopathy patients.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2012

Funding rounds raised

Total raised

$20M

from 4 investors over 4 rounds

R

Rare metabolics life sciences private limited raised $20M on April 16, 2014

Investors: EQT Life Sciences, Brandon Capital Partners, Seroba-Kernel Ltd (Ireland) and venBio Partners

FAQ